UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
September 27, 2004
------------------
In Vivo Medical Diagnostics, Inc.
------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Colorado
--------------------------------------------
(State or Other Jurisdiction of Incorporation)
000-49972 84-1579760
---------------------- -----------------------------------
(Commission File Number) (I.R.S. Employer Identification No.)
The Green House - Beechwood Business Park North
Inverness Scotland IV2 3BL
------------------------------------------- -----------
(Address of Principal Executive Offices) (Zip Code)
(Registrant's telephone number, including area code) - 011 44-1463-667-347
-------------------
Check the appropriate box below if the form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[] Pre-commencement communications pursuant to Rule 14-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Section 8 - Other Events
Sports Information and Publishing Company has changed its name to In Vivo
Medical Diagnostics and will trade under a new Symbol: IVVO.
Section 9 - Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.
(c) Exhibits
99 Company Issued Press Release on September 27, 2004
The Company issued a press release on September 27, 2004, a copy of which is
attached hereto as Exhibit 99.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
IN VIVO MEDICAL DIAGNOSTICS, INC.
Dated: September 27, 2004 By: /s/ Brian Cameron
-----------------------------
Brian Cameron, Authorized Signatory,
President and Chief Executive Officer